Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 HalliburtonPublic Joint Stock Company Gazprom NeftSubsea 7SchlumbergerCore Laboratories
SymbolNYSE:HALOTCMKTS:GZPFYOTCMKTS:SUBCYNYSE:SLBNYSE:CLB
Price Information
Current Price$20.69$23.01$10.39$26.29$27.53
52 Week RangeHoldHoldHoldBuyHold
MarketRank™
Overall Score2.21.70.72.31.5
Analysis Score2.20.00.02.31.1
Community Score3.52.32.13.22.1
Dividend Score1.72.50.02.51.7
Ownership Score1.70.00.01.71.7
Earnings & Valuation Score1.93.81.31.91.3
Analyst Ratings
Consensus RecommendationHoldHoldHoldBuyHold
Consensus Price Target$18.18N/AN/A$24.68$24.13
% Upside from Price Target-12.14% downsideN/AN/A-6.12% downside-12.37% downside
Trade Information
Market Cap$18.39 billion$21.82 billion$3.32 billion$36.76 billion$1.27 billion
Beta2.811.212.152.283.38
Average Volume10,835,8327,03613,08314,089,082471,839
Sales & Book Value
Annual Revenue$22.41 billion$39.02 billion$3.66 billion$32.92 billion$668.21 million
Price / Sales0.820.560.911.121.91
Cashflow$2.96 per share$9.55 per share$1.84 per share$4.21 per share$1.88 per share
Price / Cash6.992.415.666.2514.62
Book Value$9.14 per share$36.18 per share$16.81 per share$17.46 per share$4.10 per share
Price / Book2.260.640.621.516.71
Profitability
Net Income$-1,131,000,000.00$6.20 billion$-83,600,000.00$-10,137,000,000.00$101.98 million
EPS$1.24$6.66$0.05$1.47$1.79
Trailing P/E RatioN/A12.57N/AN/AN/A
Forward P/E Ratio28.3432.4141.5632.8632.01
P/E Growth2.22N/AN/A5.7712.83
Net Margins-26.60%5.75%-33.70%-40.15%-19.02%
Return on Equity (ROE)11.10%5.42%-9.32%7.34%45.39%
Return on Assets (ROA)3.08%3.05%-6.67%2.46%6.74%
Dividend
Annual Payout$0.18$0.52N/A$0.50$0.04
Dividend Yield0.87%2.26%N/A1.90%0.15%
Three-Year Dividend Growth-56.25%N/AN/A-56.25%-87.27%
Payout Ratio14.52%7.81%N/A34.01%2.23%
Years of Consecutive Dividend Growth1 YearsN/AN/A1 Years1 Years
Debt
Debt-to-Equity Ratio1.85%0.37%0.04%1.33%2.64%
Current Ratio2.30%0.97%1.16%1.22%0.99%
Quick Ratio1.64%0.66%1.14%0.92%0.74%
Ownership Information
Institutional Ownership Percentage75.37%N/AN/A73.19%92.69%
Insider Ownership Percentage0.48%N/A1.00%0.58%1.11%
Miscellaneous
Employees40,00066,5004,79186,0003,700
Shares Outstanding888.61 million948.26 million319.13 million1.40 billion46.24 million
Next Earnings Date4/21/2021 (Confirmed)5/27/2021 (Estimated)4/29/2021 (Confirmed)4/23/2021 (Confirmed)4/21/2021 (Confirmed)
OptionableOptionableNot OptionableNot OptionableOptionableOptionable
SourceHeadline
Core Laboratories: Growth Should Continue After The Economy ReopensCore Laboratories: Growth Should Continue After The Economy Reopens
seekingalpha.com - April 18 at 6:38 PM
Core Laboratories (NYSE:CLB) & Cal Dive International (OTCMKTS:CDVIQ) Critical ReviewCore Laboratories (NYSE:CLB) & Cal Dive International (OTCMKTS:CDVIQ) Critical Review
americanbankingnews.com - April 14 at 6:44 PM
Heres Why Core Laboratories (NYSE:CLB) Has A Meaningful Debt BurdenHere's Why Core Laboratories (NYSE:CLB) Has A Meaningful Debt Burden
nasdaq.com - April 12 at 5:09 PM
$111.62 Million in Sales Expected for Core Laboratories (NYSE:CLB) This Quarter$111.62 Million in Sales Expected for Core Laboratories (NYSE:CLB) This Quarter
americanbankingnews.com - April 9 at 3:52 AM
 Analysts Expect Core Laboratories (NYSE:CLB) Will Announce Earnings of $0.15 Per Share Analysts Expect Core Laboratories (NYSE:CLB) Will Announce Earnings of $0.15 Per Share
americanbankingnews.com - April 7 at 8:16 AM
$0.15 EPS Expected for Core Laboratories (NYSE:CLB) This Quarter$0.15 EPS Expected for Core Laboratories (NYSE:CLB) This Quarter
americanbankingnews.com - April 7 at 8:16 AM
Core Laboratories (NYSE:CLB) Shares Gap Up to $28.58Core Laboratories (NYSE:CLB) Shares Gap Up to $28.58
americanbankingnews.com - April 6 at 10:40 AM
Morgan Stanley Raises Core Laboratories (NYSE:CLB) Price Target to $38.00Morgan Stanley Raises Core Laboratories (NYSE:CLB) Price Target to $38.00
americanbankingnews.com - March 31 at 9:28 AM
Core Laboratories (NYSE:CLB) Price Target Raised to $38.00 at Morgan StanleyCore Laboratories (NYSE:CLB) Price Target Raised to $38.00 at Morgan Stanley
marketbeat.com - March 31 at 8:42 AM
12-month price target for Core Laboratories N.V. (NYSE:CLB) now sits at $4412-month price target for Core Laboratories N.V. (NYSE:CLB) now sits at $44
marketingsentinel.com - March 27 at 3:30 PM
Estimating The Intrinsic Value Of Core Laboratories N.V. (NYSE:CLB)Estimating The Intrinsic Value Of Core Laboratories N.V. (NYSE:CLB)
finance.yahoo.com - March 27 at 10:29 AM
Core Laboratories (NYSE:CLB) Price Target Increased to $38.00 by Analysts at Morgan StanleyCore Laboratories (NYSE:CLB) Price Target Increased to $38.00 by Analysts at Morgan Stanley
americanbankingnews.com - March 25 at 10:48 AM
Why Core Laboratories Shares Popped 7.1% TodayWhy Core Laboratories' Shares Popped 7.1% Today
fool.com - March 24 at 4:39 PM
Why Core Laboratories Stock Fell 6% TodayWhy Core Laboratories Stock Fell 6% Today
finance.yahoo.com - March 23 at 2:26 PM
Core Laboratories First Quarter 2021 Webcast At 7:30 A.M. CDT / 2:30 P.M. CEST On April 22, 2021Core Laboratories' First Quarter 2021 Webcast At 7:30 A.M. CDT / 2:30 P.M. CEST On April 22, 2021
finance.yahoo.com - March 22 at 6:22 PM
Ariel Investments: ‘Core Lab (CLB) Generated a Significant Amount of Free Cash Flow’Ariel Investments: ‘Core Lab (CLB) Generated a Significant Amount of Free Cash Flow’
finance.yahoo.com - March 9 at 3:01 PM
Oscilloscope Laboratories Acquires Grain Entrapment Drama ‘Silo’Oscilloscope Laboratories Acquires Grain Entrapment Drama ‘Silo’
uk.finance.yahoo.com - March 5 at 7:57 AM
5Gs selective roll out in India by 2021 end (IANS Exclusive)5G's selective roll out in India by 2021 end (IANS Exclusive)
glamsham.com - February 26 at 7:39 AM
Why Core Laboratories Shares Plunged 11.9% TodayWhy Core Laboratories Shares Plunged 11.9% Today
finance.yahoo.com - February 23 at 6:39 PM
Schlumberger And Core Laboratories: Oilfield Service Firms In An Oil UpswingSchlumberger And Core Laboratories: Oilfield Service Firms In An Oil Upswing
seekingalpha.com - February 18 at 7:40 AM
Core LaboratoriesCore Laboratories
fool.com - February 7 at 7:17 PM
Core Laboratories N.V. (CLB) CEO Larry Bruno on Q4 2020 Results - Earnings Call TranscriptCore Laboratories N.V. (CLB) CEO Larry Bruno on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - January 30 at 11:39 AM
Core Laboratories (CLB) Q4 2020 Earnings Call TranscriptCore Laboratories (CLB) Q4 2020 Earnings Call Transcript
finance.yahoo.com - January 28 at 8:00 PM
Core Labs (CLB) Q4 Earnings and Revenues Beat EstimatesCore Labs' (CLB) Q4 Earnings and Revenues Beat Estimates
finance.yahoo.com - January 28 at 3:00 PM
Why Core Laboratories Stock Rose 5% and Fell 5% on the Same DayWhy Core Laboratories Stock Rose 5% and Fell 5% on the Same Day
finance.yahoo.com - January 28 at 3:00 PM
Core Laboratories (CLB) Q4 Earnings and Revenues Top EstimatesCore Laboratories (CLB) Q4 Earnings and Revenues Top Estimates
finance.yahoo.com - January 27 at 11:22 PM
DateCompanyBrokerageAction
2/1/2021HalliburtonPiper SandlerUpgrade
1/25/2021HalliburtonAtlantic SecuritiesUpgrade
1/20/2021HalliburtonRoyal Bank of CanadaReiterated Rating
1/20/2021HalliburtonMorgan StanleyBoost Price Target
1/20/2021HalliburtonNorthland SecuritiesBoost Price Target
1/20/2021HalliburtonCredit Suisse GroupBoost Price Target
1/20/2021HalliburtonCowenBoost Price Target
1/20/2021HalliburtonStephensUpgrade
12/16/2020HalliburtonBank of AmericaUpgrade
12/15/2020HalliburtonSmith Barney CitigroupUpgrade
12/15/2020HalliburtonCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellUpgrade
12/10/2020HalliburtonHSBCDowngrade
12/7/2020HalliburtonTudor PickeringUpgrade
10/12/2020HalliburtonExane BNP ParibasInitiated Coverage
10/1/2020HalliburtonBMO Capital MarketsInitiated Coverage
8/17/2020HalliburtonWells Fargo & CompanyReiterated Rating
8/13/2020HalliburtonThe Goldman Sachs GroupUpgrade
7/21/2020HalliburtonRaymond JamesBoost Price Target
7/21/2020HalliburtonStifel NicolausBoost Price Target
2/11/2020Public Joint Stock Company Gazprom NeftVTB CapitalDowngrade
3/29/2021Subsea 7DNB MarketsDowngrade
3/5/2021Subsea 7Jefferies Financial GroupUpgrade
3/4/2021Subsea 7Berenberg BankReiterated Rating
2/26/2021Subsea 7SEB EquitiesDowngrade
11/24/2020Subsea 7UBS GroupUpgrade
12/10/2018Subsea 7Sanford C. BernsteinUpgrade
3/2/2021SchlumbergerBarclaysBoost Price Target
1/26/2021SchlumbergerGriffin SecuritiesReiterated Rating
1/26/2021SchlumbergerArgusBoost Price Target
12/18/2020SchlumbergerJPMorgan Chase & Co.Boost Price Target
10/19/2020SchlumbergerScotiabankBoost Price Target
7/24/2020SchlumbergerEvercore ISIReiterated Rating
1/11/2021Core LaboratoriesWolfe ResearchUpgrade
9/29/2020Core LaboratoriesABN AmroUpgrade
(Data available from 4/19/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.